ARC Foundation for Cancer Research

• NCT03386929

  Collaborator, Phase 1/2, Terminated, 15 people, 29 Dec 2017

• NCT02322853

  Collaborator, Phase 2, Terminated, 8 people, 23 Dec 2014

• Annabelle KLEIN

  Doctoral, Identification de nouveaux marqueurs de la senescence cellulaire médiée par p21, arc-doctoral-2023-klein-annabelle-institut-de-genetique-et-de-biologie-moleculaire-et-cellulaire-illkirch, 2023, 1 Jan 2023

Sources: openalex.org

• Tumor Loss of the Y Chromosome Defines a Biological Phenotype Associated With Resistance to Radiation Therapy Across Cancer Types

  10 Sept 2026

• Senescent cells maintain viability through adhesion-dependent fragmentation that promotes debris deposition

  PJA20181208104, 28 Aug 2026

• Combined low-dose thoracic computed tomography and circulating tumor cell screening for cancer in ever smokers with peripheral arterial disease: A prospective multicenter cohort study

  22 Aug 2026

• Cellular reprogramming beyond pluripotency

  PJA 20181208231, 20 Mar 2026

• Induction of senescence during postpartum mammary gland involution supports tissue remodeling and promotes postpartum tumorigenesis

  PJA 20181208231, 18 Feb 2026

• The Proinflammatory Secretome of Senescent Cells Can Be Controlled by a HIF2A-Dependent Upregulation and a FURIN-Dependent Cleavage of the ANGPTL4 Secreted Factor

  ARCPJA2021060003918, 5 Dec 2025

Sources: api.crossref.org